Pressmeddelanden

CEO COMMENT ON NOMINATION TO BECOME NEXT CHAIRMAN Founder and CEO, Dorte X. Gram of PILA PHARMA AB (publ) (FN STO: PILA) comments on recent Company news that she is nominated to become the next Chairman of the Board. PILA PHARMA...
REG
KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB Aktieägarna i PILA PHARMA AB, org.nr 556966-4831 ("PILA PHARMA" eller "Bolaget"), kallas härmed till årsstämma tisdag den 18 april 2024 kl. 15.00 hos MAQS Advokatbyrå, Gibraltarg...
REG
PILA PHARMA PUBLISHES THE ANNUAL REPORT 2023 PILA PHARMA AB (publ) (FN STO: PILA) announces that the annual report (in Swedish) is now available on the Company´s homepage, https://pilapharma.com/investors/finansiell-informa...
REG
PILA PHARMA ADVANCES THE PUBLICATION OF THE ANNUAL REPORT 2023 PILA PHARMA AB (publ) (FN STO: PILA) has decided to advance the publication of its annual report for the financial year ended 31 December 2023 to the 20 March 2024. The previous...
PILA PHARMA INVITES YOU TO INVESTOR MEETINGS PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to participate in these upcoming investor events:___________AktieInfo Investor Evening (Scandic Sydhavnen, Copenhagen, Den...
PILA PHARMA INVITES TO INVESTOR MEETING IN KOLDING, DENMARK PILA PHARMA AB (publ) (FN STO: PILA) hereby invites local Danish investors to participate in the event we organize together with the regional office of Danish Shareholders Associ...
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Redeye Online Investor Event (ONLINE / Stockholm, Sweden) Presentation
Dansk Aktionærforening Fyn [INVESTOR DAGEN] (Odense, Denmark) Presentation
Aktiespararna Online Lifescience Day (ONLINE / Stockholm, Sweden) Presentation
Årsstämma Årsstämma
Halvårsrapport 2024 Delårsrapport

Om PILA PHARMA

Prenumerera

Få löpande information från PILA PHARMA via e-post.

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn PILA ISIN-kod SE0015988274 Certified Adviser Aqurat Fondkommission